George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 12.50
Ask: 13.50
Change: 5.575 (75.08%)
Spread: 1.00 (8.00%)
Open: 9.65
High: 13.50
Low: 9.65
Prev. Close: 7.425
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

31 Aug 2023 07:00

RNS Number : 8613K
Carclo plc
31 August 2023
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

31 August 2023

 

Carclo plc

 

("Carclo" or the "Group")

 

Trading Update

 

 

Carclo plc, the leading global provider of high-precision components, offering comprehensive services from mould design, automation, and production to assembly and printing, serving the life sciences, aerospace, optics, and tech sectors, announces a trading update.

Our CTP Design & Engineering business has showcased remarkable resilience and growth, with sales figures exceeding expectations year to date. The order book remains robust, reflecting the trust our clients place in our capabilities and the market's recognition of our advanced solutions. This strong position underscores our commitment to innovation and our ability to meet the evolving needs of our clients, further solidifying Carclo's reputation as a leader in the sector.

In our CTP US Manufacturing Solutions business, we are navigating through a tight labour market, which has presented operational challenges across all of our US facilities. The ongoing restructuring reflects our commitment to aligning our operations more closely with market demand. While the initiation of a significant project with a major customer has seen some delays, and we've observed a softer demand in the early part of the year due to destocking at our customers, we remain optimistic about the future trajectory. Our proactive approach will ensure that we're positioned to address these short-term challenges without compromising our long-term vision.

Our CTP EMEA Manufacturing Solutions business has emerged stronger post-restructuring. The results are evident in our enhanced operational performance, allowing us to keep pace with the growth of the EMEA market. With long-run operations solidified in the UK and medium flexible runs in our Czech facility, we've achieved a harmonious blend of efficiency and flexibility. Furthermore, improvements in material utilisation underscore our commitment to operational excellence.

The Aerospace division is experiencing a notable resurgence, with indicators showing the market is rebounding to its pre-COVID vibrancy. This revival is not merely a reflection of the broader industry trend but is also a testament to our strategic and proactive business development initiatives. Through targeted efforts, we've not only captured new opportunities but also strengthened existing partnerships. These achievements, combined with our unwavering commitment to quality and innovation, have further solidified Carclo's highly-regarded position within the aerospace sector.

Financially, our focus on cash conversion and margin improvement, rather than just sales growth, is beginning to reflect positively on our balance sheet. The strategy to bolster our balance sheet's health is evident across our operations. The compensation received from the cancelled manufacturing framework agreement has been utilised to reduce our bank debt. In an environment of rising interest rates, our emphasis on cash management becomes even more pivotal.

We will provide more details when we release our interim results for the six months ending 30 September 2023 later this year.

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc 01924 268040

Frank Doorenbosch - Chief Executive Officer

Eric Hutchinson - Chief Financial Officer

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVRTDIIVIV
Date   Source Headline
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.